Search Results - Michael Gerken

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    VP 16-213 in acute myelogenous leukaemia

    VP 16-213 in acute myelogenous leukaemia by I. E. Smith, Hugh M. Clink, Michael Gerken, T J McElwain

    Published 1976
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Risk factors for lung cancer among nonsmoking women

    Risk factors for lung cancer among nonsmoking women by Michaela Kreuzer, Joachim Heinrich, Lothar Kreienbrock, Angelika Schaffrath Rosario, Michael Gerken, H.‐Erich Wichmann

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma

    Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma by Christina Hackl, Peter J. Neumann, Michael Gerken, Martin Loss, Monika Klinkhammer‐Schalke, Hans J. Schlitt

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Laparoscopic and open surgery in rectal cancer patients in Germany: short and long-term results of a large 10-year population-based cohort

    Laparoscopic and open surgery in rectal cancer patients in Germany: short and long-term results of a large 10-year population-based cohort by Valentin Schnitzbauer, Michael Gerken, Stefan Benz, Vinzenz Völkel, Teresa Draeger, Alois Fürst, Monika Klinkhammer‐Schalke

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Risk Factors for Lung Cancer in Young Adults

    Risk Factors for Lung Cancer in Young Adults by Michaela Kreuzer, Lothar Kreienbrock, Michael Gerken, Joachim Heinrich, I. Bruske-Hohlfeld, K.-M. Müller, H.‐Erich Wichmann

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera

    Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera by Thomas Papathemelis, Evi Jablonski, Anton Scharl, Tanja Hauzenberger, Michael Gerken, Monika Klinkhammer‐Schalke, Matthias Hipp, Sophia Scharl

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients

    Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients by Rosa Schmuck, Michael Gerken, E. Teegen, Isabell Krebs, Monika Klinkhammer‐Schalke, Felix Aigner, Johann Pratschke, Beate Rau, Stefan Benz

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Clinical, therapeutic and prognostic differences between male and female patients with breast cancer—a comparison of 2510 men and 307,634 women in a registry-based study in Germany

    Clinical, therapeutic and prognostic differences between male and female patients with breast cancer—a comparison of 2510 men and 307,634 women in a registry-based study in Germany... by Marion Graf, Michael Gerken, Monika Klinkhammer‐Schalke, Simone Schrodi, Armin Pauer, Karla Geiss, Olaf Ortmann, Elisabeth C Sturm-Inwald

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Initial cancer treatment in certified versus non-certified hospitals

    Initial cancer treatment in certified versus non-certified hospitals by Jochen Schmitt, Monika Klinkhammer‐Schalke, Veronika Bierbaum, Michael Gerken, Christoph Bobeth, M Rößler, Patrik Dröge, Thomas Ruhnke, Christian Günster, Kees Kleihues-van Tol, Olaf Schoffer

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer

    Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer by Maria Eleni Hatzipanagiotou, Miriam Pigerl, Michael Gerken, Sophie Räpple, Verena Zeltner, Madeleine Hetterich, Péter Ugocsai, Elisabeth C. Inwald, Monika Klinkhammer‐Schalke, Olaf Ortmann, Stephan Seitz

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center

    Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center by Amer Haj, Christian Doenitz, Karl-Michael Schebesch, Denise Ehrensberger, Peter Hau, Kurt Putnik, Markus J. Riemenschneider, Christina Wendl, Michael Gerken, Tobias Pukrop, Alexander Brawanski, Martin Proescholdt

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Use of metformin and survival of patients with high‐grade glioma

    Use of metformin and survival of patients with high‐grade glioma by Corinna Seliger, Christian A. Luber, Michael Gerken, Julia Schaertl, Martin Proescholdt, Markus J. Riemenschneider, Christoph Meier, Ulrich Bogdahn, Michael F. Leitzmann, Monika Klinkhammer‐Schalke, Peter Hau

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany

    Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany by Sven Voigtländer, Amir Hakimhashemi, Nina Grundmann, Martin Radespiel‐Tröger, Elisabeth C. Inwald, Olaf Ortmann, Michael Gerken, Stefanie J. Klug, Monika Klinkhammer‐Schalke, Martin Meyer, Jacqueline Müller‐Nordhorn

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study

    Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study by Martin Roessler, Jochen Schmitt, Christoph Bobeth, Michael Gerken, Kees Kleihues-van Tol, Christoph Reißfelder, Bettina Rau, Marius Distler, Pompiliu Piso, Christian Günster, Monika Klinkhammer‐Schalke, Olaf Schoffer, Veronika Bierbaum

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Treatment in certified cancer centers is related to better survival in patients with colon and rectal cancer: evidence from a large German cohort study

    Treatment in certified cancer centers is related to better survival in patients with colon and rectal cancer: evidence from a large German cohort study by Veronika Bierbaum, Christoph Bobeth, Martin Roessler, Michael Gerken, Kees Kleihues-van Tol, Christoph Reißfelder, Alois Fürst, Christian Günster, Patrik Dröge, Thomas Ruhnke, Monika Klinkhammer‐Schalke, Jochen Schmitt, Olaf Schoffer

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer

    Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer by Olaf Schoffer, Pauline Wimberger, Michael Gerken, Veronika Bierbaum, Christoph Bobeth, M Rößler, Patrik Dröge, Thomas Ruhnke, Christian Günster, Kees Kleihues-van Tol, Theresa Link, Anton Scharl, Elisabeth C. Inwald, Karin Kast, Thomas Papathemelis, Olaf Ortmann, Monika Klinkhammer‐Schalke, Jochen Schmitt

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: